Fabrazyme--recombinant protein treatment for Fabry's disease.
Barngrover
Debra
D
Therapeutics Operations Management, Framingham, MA 01701-9322, USA. debra.barngrover@genzyme.com
D000795:Fabry Disease / Q000188:drug therapy* / Q000201:enzymology; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000627:therapeutic use*; D008297:Male; D009113:Muramidase / Q000378:metabolism; D000519:alpha-Galactosidase / Q000378:metabolism / Q000627:therapeutic use*
D007527:Isoenzymes; D009113:Muramidase; D000519:alpha-Galactosidase; C459420:agalsidase beta